Researchers identified the post-fast refeeding period as a distinct state with greater potential for tumor proliferation compared to the fasted or continuously fed state.

A 2023 study found that participants who consumed fast food for 20% or more of their meals accumulated excessive fat in their livers, highlighting the potential impact of dietary choices on liver health.

Chemotherapy-free regimens for Ph+ ALL have shown complete response rates of 94-100% with minimal toxicity, potentially eliminating the need for stem cell transplant in many patients.

The STRIDE regimen demonstrated a 30.7% survival rate at 36 months, compared to 20.2% with sorafenib, suggesting potential long-term benefits for patients with unresectable hepatocellular carcinoma.

The trend towards healthcare consolidation continues, with nearly 1,900 hospital mergers reported over two decades and significant variations in ownership changes between hospitals and nursing homes.

UnitedHealthcare’s decision to bundle G2211 into E/M payments for commercial plans signifies a shift in reimbursement strategies that oncologists need to address promptly.